PMID: 12133653Jul 23, 2002Paper

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial

F FollathSteering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study


Levosimendan, a novel calcium sensitiser, improves myocardial contractility without causing an increase in myocardial oxygen demand. We compared the effects of levosimendan and dobutamine on haemodynamic performance and clinical outcome in patients with low-output heart failure. Patients were recruited into a multicentre, randomised, double-blind, double-dummy, parallel-group trial. Under continuous haemodynamic monitoring, an initial loading dose of levosimendan of 24 microg/kg was infused over 10 min, followed by a continuous infusion of 0.1 microg kg(-1) min(-1) for 24 h. Dobutamine was infused for 24 h at an initial dose of 5 microg kg(-1) min(-1) without a loading dose. The infusion rate was doubled if the response was inadequate at 2h. The primary endpoint was the proportion of patients with haemodynamic improvement (defined as an increase of 30% or more in cardiac output and a decrease of 25% or more in pulmonary-capillary wedge pressure) at 24 h. Analyses were by intention to treat. 103 patients were assigned levosimendan and 100 dobutamine. The primary haemodynamic endpoint was achieved in 29 (28%) levosimendan-group patients and 15 (15%) in the dobutamine group (hazard ratio 1.9 [95% CI 1.1-3.3]; p=0.022). At 180 days...Continue Reading


May 1, 1995·Journal of Cardiovascular Pharmacology·H HaikalaI B Lindén
Sep 1, 1995·Journal of Molecular and Cellular Cardiology·H HaikalaI B Lindén
Jul 1, 1997·Anesthesia and Analgesia·I N JamaliD C Warltier
Feb 5, 1998·European Journal of Pharmacology·M K Lancaster, S J Cook
Sep 15, 1998·Lancet·N Sharpe, R Doughty
Jun 17, 2000·European Journal of Heart Failure·S ThackrayJ G Cleland
Aug 10, 2000·European Journal of Heart Failure·J G ClelandA Boddy
Nov 25, 2000·Journal of the American College of Cardiology·M S NieminenW J Remme
Dec 5, 2000·Clinical Pharmacology and Therapeutics·H UkkonenL M Voipio-Pulkki
May 23, 2001·Drugs·D P FiggittK L Goa

❮ Previous
Next ❯


Feb 22, 2012·Medizinische Klinik, Intensivmedizin und Notfallmedizin·U Janssens
Nov 30, 2006·Der Anaesthesist·S RehbergM Westphal
Mar 21, 2012·Der Anaesthesist·S Rasche, C Georgi
Mar 31, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Sharlene M DayJoseph M Metzger
Apr 7, 2005·Intensive Care Medicine·Andrea MorelliPaolo Pietropaoli
Aug 26, 2006·Pediatric Cardiology·Brady S Moffett, Anthony C Chang
Jul 29, 2005·Zeitschrift für Kardiologie·U C HoppeUNKNOWN Vorstand der Deutschen Gesellschaft fur Kardiologie--Herz- und Kreislaufforschung e.V
Jul 18, 2008·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Marc-Phillip HitzT Mesud Yelbuz
Jan 5, 2011·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Murat BitekerMehmet Õzkan
Mar 19, 2013·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Petri O TuomainenKeijo Peuhkurinen
Dec 26, 2013·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Simona SilvettiAlberto Zangrillo
Feb 3, 2006·Cardiovascular Drugs and Therapy·Klara BrixiusRobert H G Schwinger
Nov 24, 2006·Cardiovascular Drugs and Therapy·Martin BuskJens Erik Nielsen-Kudsk
Mar 24, 2006·Cardiovascular Drugs and Therapy·Sadi S OzdemCoskun Usta
Jul 5, 2007·Cardiovascular Drugs and Therapy·John T ParissisDimitrios Kremastinos
Aug 19, 2007·Cardiovascular Drugs and Therapy·Fatma AkarSalih Fehmi Katircioglu
May 10, 2007·Heart Failure Reviews·John T ParissisMarkku Nieminen
Dec 15, 2007·Heart Failure Reviews·Hiroyuki Yaoita, Yukio Maruyama
May 4, 2005·Current Cardiology Reports·Jonathan D Sackner-Bernstein
Jul 23, 2005·Current Heart Failure Reports·Clyde W YancyUNKNOWN ADHERE Scientific Advisory Committee
Sep 22, 2007·Current Heart Failure Reports·Prashant Vaishnava, Eldrin F Lewis
Jul 2, 2003·Current Treatment Options in Cardiovascular Medicine·Steven J. Hussein, John R. Teerlink
Jan 29, 2008·Current Treatment Options in Cardiovascular Medicine·Ulf Landmesser, Helmut Drexler
Oct 23, 2009·Current Treatment Options in Cardiovascular Medicine·Avihu Z Gazit, Phineas P Oren
Sep 16, 2010·Current Treatment Options in Cardiovascular Medicine·Mustafa Toma, Randall C Starling
Nov 26, 2003·Intensive & Critical Care Nursing : the Official Journal of the British Association of Critical Care Nurses·Paula Mason
Nov 25, 2005·Nature Clinical Practice. Cardiovascular Medicine·Ulf Landmesser, Helmut Drexler
Nov 10, 2012·Pediatric Research·Adelina PellicerFernando Cabañas
Dec 20, 2013·Assay and Drug Development Technologies·Cheng-Chen HuangKarl P Peterson
May 23, 2009·British Journal of Anaesthesia·N MongardonM Singer
Jan 25, 2011·British Journal of Anaesthesia·H LeppikangasL Lindgren

❮ Previous
Next ❯

Related Concepts

Related Feeds


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.